References
- Seidl R, Peyrl A, Nicham R, et al. A taurine and caffeine-containing drink stimulates cognitive performance and well-being. Amino Acids. 2000;19:635–642.
- Juhn M. Popular sports supplements and ergogenic aids. Sports Med. 2003;33:921–939.
- Jabbar SB, Hanly MG. Fatal caffeine overdose: a case report and review of literature. Am J Forensic Med Pathol. 2013;34:321–324.
- Poussel M, Kimmoun A, Levy B, et al. Fatal cardiac arrhythmia following voluntary caffeine overdose in an amateur body-builder athlete. Int J Cardiol. 2013;166:e41–e42.
- Garriott JC, Simmons LM, Poklis A, et al. Five cases of fatal overdose from caffeine-containing “look-alike” drugs. J Anal Toxicol. 1985;9:141–143.
- Gurley BJ, Steelman SC, Thomas SL. Multi-ingredient, caffeine-containing dietary supplements: history, safety, and efficacy. Clin Ther. 2015;37:275–301.
- Haller CA, Benowitz NL, Jacob P. 3rd. Concentrations of ephedra alkaloids and caffeine in commercial dietary supplements. J Anal Toxicol. 2004;28:145–151.
- Jacob P 3rd, Haller CA, Duan M, et al. Determination of ephedra alkaloid and caffeine concentrations in dietary supplements and biological fluids. J Anal Toxicol. 2004;28:152–159.
- Gurley BJ, Gardner SF, Hubbard MA. Content versus label claims in ephedra-containing dietary supplements. Am J Health Syst Pharm. 2000;57:963–969.
- Young C, Oladipo O, Frasier S, et al. Hemorrhagic stroke in young healthy male following use of sports supplement Jack3d. Mil Med. 2012;177:1450–1454.
- Eliason MJ, Eichner A, Cancio A, et al. Case reports: death of active duty soldiers following ingestion of dietary supplement containing 1,3-diethylamylamine (DMAA). Mil Med. 2012;177: 1455–1459.
- Armstrong M. Atrial fibrillation with rapid ventricular response following use of dietary supplement containing 1,3-dimethylamylamine and caffeine. J Spec Oper Med. 2012;12:1–4.
- Smith TB, Staub BA, Natarajan GM, et al. Acute myocardial infarction associated with dietary supplements containing 1,3-dimethylamylamine and Citrus aurantium. Tex Heart Inst J. 2014;41:70–72.
- Forrester MB. Exposures to 1,3-dimethylamylamine-containing products reported to Texas poison centers. Hum Exp Toxicol. 2013;32:18–23.
- Venhuis B, Keizers P, van Riel A, et al. A cocktail of synthetic stimulants found in a dietary supplement associated with serious adverse events. Drug Test Anal. 2014;6:578–581.
- Wu AH, Gerona R, Armenian P, et al. Role of liquid chromatography-high resolution mass spectrometry (LC-HR/MS) in clinical toxicology. Clin Toxicol (Phila). 2012;50:733–742.
- Kole J, Barnhill A. Caffeine content labeling: a missed opportunity for promoting personal and public health. J Caffeine Res. 2013;3:108–113.
- Andrews KW, Schweitzer A, Zhao C, et al. The caffeine contents of dietary supplements commonly purchased in the US: analysis of 53 products with caffeine-containing ingredients. Anal Bioanal Chem. 2007;389:231–239.